US · chronic pain · medical devices · medtech
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Apr 2026 · $53M
Amzak Health lead, Elevage Medical Technologies, Foothill Ventures, U.S. Venture Partners (USVP), Lumira Ventures, Shangbay Capital
Reported by Ventureburn
Missing a round, or an investor who was in one? Tell us.